#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine neuroendocrine tumour Waldenstrom's macroglobulinaemia refractory Splenic marginal zone lymphoma Pemphigus Haemolytic uraemic syndrome Ocular lymphoma Chronic lymphocytic leukaemia recurrent C3 glomerulopathy Orthostatic hypotension Myotonic dystrophy Exudative retinopathy Prolymphocytic leukaemia Post transplant lymphoproliferative disorder Chronic graft versus host disease in liver Neuropathy peripheral More trials…

    Learn about Rare Diseases

    Pleomorphic leiomyosarcoma – Trials in Disease Advanced systemic mastocytosis – Treatment Gaucher’s disease type III – Trials in Disease Lymphangioma Cystic fibrosis – Diagnostics Angiosarcoma metastatic Primary immunodeficiency syndrome – Trials in Disease Amyotrophic lateral sclerosis Alternating hemiplegia of childhood – Life with Disease Antithrombin III deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZINC CHLORIDE Ambroxol Hydrochloride ARTICAINE HYDROCHLORIDE Valproate Semisodium Hydroxychloroquine Sulfate Hmb-001 MRNA-1345 Rizolipase Ethinylestradiol ANTIMETABOLITES Apitegromab Taldefgrobep Alfa Progesterone Ph. Eur. Levocarnitine Nemvaleukin Alfa IBANDRONIC ACID Ep0042 L-LEUCINE His203-Crm197 NADOFARAGENE FIRADENOVEC More therapies…

    Learn about Your Condition

    Ataxia telangiectasia Intervertebral disc protrusion Endometrial cancer Hypertriglyceridaemia Benign neoplasm of ureter Anogenital warts Congenital aplastic anaemia Osteosarcoma recurrent Osteomyelitis Tubulointerstitial nephritis Biliary adenoma Papillary thyroid cancer Endocarditis Peripheral artery angioplasty Mucopolysaccharidosis II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Laiko General Hospital Of Athens

Laiko General Hospital Of Athens

Messogion Avenue 154, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Pembrolizumab
    Austria Belgium France Germany Greece Hungary +6

  • Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    • B-cell lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Belgium Bulgaria Croatia Czechia Denmark France +11

  • Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Croatia Czechia Denmark +12

  • Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amikacin
    • Azithromycin
    • Ethambutol Hydrochloride
    Austria Belgium Denmark France Germany Greece +5

  • Study on the Effects of Deupirfenidone and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Deupirfenidone
    • Pirfenidone
    Greece Romania

  • Study Comparing Brinzolamide and Timolol Eye Drops for Patients with Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Brinzolamide
    • Timolol
    Greece

  • Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage III
    Austria Belgium France Germany Greece Hungary +6

  • Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

    Not recruiting

    2 1
    Investigated Drugs:
    • Nnc0194-0499
    • Cagrilintide
    • Semaglutide
    Belgium Bulgaria Czechia Denmark France Germany +5

  • Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • Golimumab
    • Guselkumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9
Previous Page
1 … 27 28 29 30 31 … 38
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!